SKYE

Skye Bioscience, Inc. (SKYE) ESG Analysis Analysis (2026)

Invetso Score: 5.4/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Environmental

Score: 5.0 (Moderate)

SKYE provides no disclosed R&D intensity or emissions metrics in the supplied data, leaving environmental oversight less transparent than peers with quantified transition disclosures.

Zero reported R&D-to-revenue may indicate limited climate-related innovation investment versus peers that disclose dedicated low-carbon or resource-efficiency spending.

The absence of gross margin and FCF margin data limits assessment of operational efficiency, which weakens comparability against peers that report resource-use outcomes more fully.

No evidence of environmental controversies is provided, so the main gap versus peers is disclosure depth rather than a clearly worse operating footprint.

Social

Score:

SKYE discloses no workforce, safety, or human-capital metrics in the supplied data, making social performance harder to compare than peers with broader reporting.

Zero stock-based compensation to revenue suggests limited equity-based employee alignment versus peers that use compensation structures to support retention and engagement.

The lack of disclosed social KPIs reduces visibility into labor practices and community impact, which can elevate reputational risk relative to better-disclosing peers.

No adverse social incidents are provided, so the relative weakness is incomplete disclosure rather than evidence of materially poorer social outcomes.

Governance

Score:

Leverage appears modest, with net debt to EBITDA of 0.16, which compares favorably with more levered peers and reduces balance-sheet governance pressure.

The negative debt-to-equity ratio likely reflects a distorted equity base, so capital-structure interpretation is less reliable than for peers with cleaner reporting.

Zero stock-based compensation to revenue may limit dilution concerns versus peers, but it also provides little evidence of a strong long-term incentive framework.

Overall governance positioning is constrained by sparse disclosure, leaving SKYE broadly in line with peers that lack detailed governance transparency.

Overall Score

Score:

SKYE’s ESG positioning is moderate versus peers because leverage is manageable, but limited disclosure across environmental, social, and governance metrics constrains relative strength.

Score Driver: Sparse ESG Disclosure Relative To Peers

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Skye Bioscience, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →